Gainers
- HOOKIPA Pharma HOOK stock moved upwards by 73.2% to $0.98 during Thursday's regular session. The market value of their outstanding shares is at $82.1 million.
- HeartBeam BEAT stock increased by 54.23% to $1.82. The market value of their outstanding shares is at $47.9 million.
- PetVivo Hldgs PETV shares moved upwards by 39.02% to $1.14. The market value of their outstanding shares is at $16.4 million.
- OneMedNet ONMD shares moved upwards by 37.5% to $1.1. The company's market cap stands at $35.4 million.
- Anebulo Pharmaceuticals ANEB stock moved upwards by 28.57% to $2.7. The company's market cap stands at $69.2 million.
- MeiraGTx Hldgs MGTX shares moved upwards by 27.89% to $6.28. The company's market cap stands at $399.3 million.
Losers
- Clene CLNN stock fell 41.5% to $0.3 during Thursday's regular session. The market value of their outstanding shares is at $38.7 million.
- Aclarion ACON shares fell 28.06% to $0.25. The company's market cap stands at $2.3 million.
- Panbela Therapeutics PBLA shares decreased by 24.47% to $0.91. The company's market cap stands at $4.6 million.
- Longeveron LGVN stock decreased by 22.05% to $1.26. The market value of their outstanding shares is at $29.9 million.
- Genetic Technologies GENE stock fell 15.37% to $2.16. The market value of their outstanding shares is at $8.3 million.
- Know Labs KNW shares decreased by 13.51% to $0.51. The company's market cap stands at $41.5 million. As per the news, the Q4 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ANEBAnebulo Pharmaceuticals Inc
$1.4112.8%
BEATHeartBeam Inc
$2.440.83%
CLNNClene Inc
$4.883.39%
GENEGenetic Technologies Ltd
$0.7500-1.96%
HOOKHOOKIPA Pharma Inc
$1.98-2.46%
KNWKnow Labs Inc
$0.163010.1%
LGVNLongeveron Inc
$1.74-1.69%
MGTXMeiraGTx Holdings PLC
$6.171.31%
ONMDOneMedNet Corp
$1.412.17%
PBLAPanbela Therapeutics Inc
$0.35202.20%
PETVPetVivo Holdings Inc
$0.570012.9%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in